Valentina Fonsato

This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: Fresenius Medical Care Deutschland Gmbh. Active years: 2015-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Valentina Fonsato. Retrieved from https://idiyas.com/inventor/valentina-fonsato

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 (Patent Applications = 2)

% Patents Active = 100.0

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 11(Granted Patents)

Location History:

Pecetto Torinese, IT (2015 - 2018)
Cambiano, IT (2019)

Company Filing History:

5 out of 885

Fresenius Medical Care Deutschland Gmbh

patents

Years Active: 2015-2019

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10456425 - Conditioned medium of liver progenitor cells (2019-10-29),

2. 10357519 - Conditioned medium of liver progenitor cells (2019-07-23),

3. 10105395 - Microvesicles (MVs) derived from adult stem cells for use in the therapeutic treatment of a tumor disease (2018-10-23),

4. 9717760 - Microvesicles (MVS) derived from adult stem cells for use in the therapeutic treatment of a tumor disease (2017-08-01),

5. 9034335 - Adult stem cell derived conditioned medium and/or adult stem cells for use in the therapeutic treatment of a tumor disease (2015-05-19),

Title: Valentina Fonsato: Innovator in Regenerative Medicine

Introduction

Valentina Fonsato is a prominent inventor based in Pecetto Torinese, Italy. She has made significant contributions to the field of regenerative medicine, holding a total of 5 patents. Her work focuses on innovative solutions for treating organ injuries and failures, particularly in the liver.

Latest Patents

One of her latest patents involves the conditioned medium of liver progenitor cells. This invention has been found to exert a tissue regenerating effect, making it a valuable preparation for treating injuries and organ failures. The cell-free conditioned medium is particularly useful in addressing liver-related issues, showcasing the potential of her research in regenerative medicine.

Career Highlights

Valentina Fonsato is currently associated with Fresenius Medical Care Deutschland GmbH, where she continues to advance her research and innovations. Her work has garnered attention in the medical community, highlighting her role as a key figure in the development of regenerative therapies.

Collaborations

Throughout her career, Valentina has collaborated with notable colleagues, including Maria Beatriz Herrera Sanchez and Ciro Tetta. These partnerships have further enriched her research and contributed to the success of her inventions.

Conclusion

Valentina Fonsato's contributions to regenerative medicine exemplify the impact of innovative thinking in healthcare. Her patents and ongoing research continue to pave the way for advancements in treating organ injuries and failures.

Profile summary based on public USPTO records.